Decreases in serum levels of S100 may predict response to therapy in melanoma patients treated with a polyvalent melanoma vaccine

被引：0
|
作者：
Bar, A [1 ]
Amin, P [1 ]
Reynolds, S [1 ]
Shapiro, R [1 ]
Roses, D [1 ]
Harris, M [1 ]
Bystryn, J [1 ]
机构：
[1] NYU, Sch Med, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2001年 / 117卷 / 02期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
901
引用
收藏
页码：540 / 540
页数：1
相关论文
共 50 条
  • [1] Clinical value of S100 levels in serum of malignant melanoma patients
    Natalia, S.
    Sergeeva, N. V.
    Marshutina, M. P.
    Mishunina, T. N.
    Lasutina, D. D.
    TUMOR BIOLOGY, 2007, 28 : 105 - 105
  • [2] S100 protein serum levels in cutaneous malignant melanoma
    Seregni, E
    Massaron, S
    Martinetti, A
    Illeni, MT
    Rovini, D
    Belli, F
    Agresti, R
    Greco, M
    Cascinelli, N
    Bombardieri, E
    ONCOLOGY REPORTS, 1998, 5 (03) : 601 - 604
  • [3] Elevated serum levels of S100 and survival in metastatic malignant melanoma
    J Buer
    M Probst
    A Franzke
    S Duensing
    J Haindl
    M Volkenandt
    F Wittke
    R Hoffmann
    A Ganser
    J Atzpodien
    British Journal of Cancer, 1997, 75 : 1373 - 1376
  • [4] Elevated serum levels of S100 and survival in metastatic malignant melanoma
    Buer, J
    Probst, M
    Franzke, A
    Duensing, S
    Haindl, J
    Volkenandt, M
    Wittke, F
    Hoffmann, R
    Ganser, A
    Atzpodien, J
    BRITISH JOURNAL OF CANCER, 1997, 75 (09) : 1373 - 1376
  • [5] Significance of serum protein S100 levels in screening for melanoma metastasis: does protein S100 enable early detection of melanoma recurrence?
    Schlagenhauff, B
    Schittek, B
    Ellwanger, U
    Stroebel, W
    Blum, A
    Schwarz, M
    Rassner, G
    Garbe, C
    MELANOMA RESEARCH, 2000, 10 (05) : 451 - 459
  • [6] Erratum: Elevated serum levels of S100 and survival in metastatic malignant melanoma
    J Atzpodien
    J Buer
    British Journal of Cancer, 1998, 77 : 854 - 854
  • [7] Erratum: Elevated serum levels of S100 and survival in metastatic malignant melanoma
    British Journal of Cancer, 1998, 77 (4) : 681 - 681
  • [8] Serum S100 protein in the follow-up of melanoma patients
    Sevila, A
    Ortiz, B
    Botella, R
    Nagore, E
    Sanmartín, O
    Maiquez, J
    Guillén, C
    SKIN AND ENVIRONMENT - PERCEPTION AND PROTECTION, VOLS 1 AND 2, 2001, : 675 - 678
  • [9] IMPROVED SURVIVAL OF PATIENTS WITH MELANOMA WITH AN ANTIBODY-RESPONSE TO IMMUNIZATION TO A POLYVALENT MELANOMA VACCINE
    MILLER, K
    ABELES, G
    ORATZ, R
    ZELENIUCHJACQUOTTE, A
    CUI, J
    ROSES, DF
    HARRIS, MN
    BYSTRYN, JC
    CANCER, 1995, 75 (02) : 495 - 502
  • [10] Ultraviolet B exposure could influence the interpretation of serum S100β levels in patients with malignant melanoma
    Vitzthum, J.
    Doerr, H. D.
    Meineke, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2007, 156 (04) : 772 - 773
12345